Ann Surg Oncol

1. LIN L, Lin T, Li X, Wang X, et al
   ASO Author Reflections: The Complex Role of 5-Alpha Reductase Inhibitors in Bladder Cancer.
   Ann Surg Oncol. 2025 Aug 9. doi: 10.1245/s10434-025-18073.
   

   >> Share

   
   

   
   Biochim Biophys Acta Mol Cell Res

2. SEKERES M, Lengle D, Abbey L, Kassack MU, et al
   Epigenetic targeting of DNA damage response (DDR)-related mechanisms to overcome acquired cisplatin resistance of tumor cells.
   Biochim Biophys Acta Mol Cell Res. 2025;1872:120018.
   

   >> Share

   
   

   
   Bioelectrochemistry

3. ZHANG Q, Zhai T, Chen J, Chen Z, et al
   Integrated photoelectrochemical/photothermal dual-mode biosensor with simultaneous dual-signal output for detection of bladder cancer cells HT-1376.
   Bioelectrochemistry. 2025;167:109075.
   

   >> Share

   
   

   
   Cancer

4. APOLO AB, Atiq S, Kydd AR, Chelluri R, et al
   Top advances of the year: Bladder cancer.
   Cancer. 2025;131:e70020.
   

   >> Share

   
   

   
   Cancer Biol Ther

5. LI Z, Jiang Q, Yang Q, Zhou Y, et al
   Hypoxia-induced PYCR1 regulates glycolysis and histone lactylation to promote bladder cancer progression and metastasis via SLC6A14/Glutamine metabolism.
   Cancer Biol Ther. 2025;26:2546219.
   

   >> Share

   
   

   
   Cancer Med

6. JI N, Hassouneh Z, Trecarten S, Shu ZJ, et al
   A Double-Humanized Murine Model in Bladder Cancer: A Novel Preclinical Model for Cancer Immunology Research.
   Cancer Med. 2025;14:e71150.
   

   >> Share

   
   

   
   Cancers (Basel)

7. SHYR CR, Wu CF, Yang KC, Ma WL, et al
   Evaluating Therapeutic Efficacy of Intravesical Xenogeneic Urothelial Cell Treatment Alone and in Combination with Chemotherapy or Immune Checkpoint Inhibition in a Mouse Non-Muscle-Invasive Bladder Cancer Model.
   Cancers (Basel). 2025;17:2448.
   

   >> Share

   
   
8. RAHMAN SN, Martin DT, Keervani K, James S, et al
   Evaluating the Therapeutic Role of Lymph Node Dissection in Variant Subtype Bladder Cancer.
   Cancers (Basel). 2025;17:2536.
   

   >> Share

   
   
9. PALENCIA PS, Sivanesan N, Rahman S, Ghali F, et al
   Partial Cystectomy for Muscle-Invasive Bladder Cancer.
   Cancers (Basel). 2025;17:2562.
   

   >> Share

   
   

   
   Clin Epigenetics

10. GOEL A, Tura BJ, Stockton JD, Tovey N, et al
    Detection of genome-wide methylation changes in bladder cancer by long-read sequencing of urinary DNA.
    Clin Epigenetics. 2025;17:141.
    

    >> Share

    
    

    
    Clin Med Insights Oncol

11. CHEN Y, Xian P, Lu J, Zhang L, et al
    Purine Nucleoside Phosphorylase (PNP) as a Biomarker and Therapeutic Target in Muscle-Invasive Bladder Cancer.
    Clin Med Insights Oncol. 2025;19:11795549251359145.
    

    >> Share

    
    

    
    Cureus

12. GAO F, Yao L, Teng J, Zhao F, et al
    The Temporal Trends and Attributed Risk Burden of Kidney Cancer, Bladder Cancer, and Prostate Cancer in China From 1990 to 2021.
    Cureus. 2025;17:e87583.
    

    >> Share

    
    

    
    Curr Opin Urol

13. GUERRERO-RAMOS F, Gomez-Canizo C, Hernandez-Arroyo M, Subiela JD, et al
    Hyperthermic intravesical chemotherapy for Bacillus Calmette-Guerin-unresponsive nonmuscle-invasive bladder cancer.
    Curr Opin Urol. 2025 Aug 14. doi: 10.1097/MOU.0000000000001329.
    

    >> Share

    
    

    
    Diagnostics (Basel)

14. YILDIZ HA, Deger MD, Aslan G
    How Accurately Can Urologists Predict Eligible Patients for Immediate Postoperative Intravesical Chemotherapy in Bladder Cancer?
    Diagnostics (Basel). 2025;15:1856.
    

    >> Share

    
    

    
    Environ Res

15. YI B, Zhao Z, Gao X, Zhao D, et al
    Antimony Exposure Induces Bladder Cancer Metastasis Via Activation of the SUMOylation-Dependent TGF-beta/Smad2/3 Axis.
    Environ Res. 2025 Aug 12:122589. doi: 10.1016/j.envres.2025.122589.
    

    >> Share

    
    

    
    Eur J Med Res

16. HE Z, Gong C, Gu J, Wang W, et al
    Potential of APOBEC3B as a therapeutic target and its role in bladder cancer onset and progression.
    Eur J Med Res. 2025;30:740.
    

    >> Share

    
    

    
    Eur Radiol Exp

17. YAMAMOTO K, Yamamoto K, Juri H, Azuma H, et al
    Vesical perfusion volume and internal iliac pressure during double balloon-occluded arterial infusion chemotherapy for bladder cancer.
    Eur Radiol Exp. 2025;9:72.
    

    >> Share

    
    

    
    Fr J Urol

18. MAUGER DE VARENNES A, Mermier M, Khene ZE, Gasmi A, et al
    Robot-assisted tubeless radical cystectomy: Is the absence of ureteral drainage a mistake?
    Fr J Urol. 2025;35.
    

    >> Share

    
    

    
    Front Oncol

19. GUERRERO QUILES C, Fahy S, Bartak M, Gonzalez Abalos J, et al
    Radiation-induced extracellular matrix remodelling drives prognosis and predicts radiotherapy response in muscle-invasive bladder cancer.
    Front Oncol. 2025;15:1616943.
    

    >> Share

    
    

    
    Indian J Cancer

20. BATRA R, Yadav S, Chaure M, Garg S, et al
    Bladder preserving approach for treatment of primary osteogenic sarcoma of bladder: A rare case report.
    Indian J Cancer. 2025;62:305-307.
    

    >> Share

    
    

    
    Int Immunopharmacol

21. XU J, Wang G, Wang M, Xu X, et al
    Pedunculoside regulates tumor immune microenvironment and malignant characteristics of bladder cancer by TRAF6 mediated M2 macrophage polarization.
    Int Immunopharmacol. 2025;164:115301.
    

    >> Share

    
    

    
    Int J Mol Sci

22. DAVIS E, Caggiano LJ, Munholland H, Basu R, et al
    Growth Hormone Signaling in Bladder Cancer: Transcriptomic Profiling of Patient Samples and In Vitro Evidence of Therapy Resistance via ABC Transporters and EMT Activation.
    Int J Mol Sci. 2025;26:7113.
    

    >> Share

    
    
23. FLORES-ESTRADA JJ, Jimenez A, Victoria-Acosta G, Cortes-Malagon EM, et al
    Nuclear Receptors in Bladder Cancer: Insights into miRNA-Mediated Regulation and Potential Therapeutic Implications.
    Int J Mol Sci. 2025;26:7340.
    

    >> Share

    
    
24. GOMEZ BB, Casas-Nebra FJ, Perez-Fentes D, Bravo SB, et al
    Variations in Circulating Tumor Microenvironment-Associated Proteins in Non-Muscle Invasive Bladder Cancer Induced by Mitomycin C Treatment.
    Int J Mol Sci. 2025;26:7413.
    

    >> Share

    
    
25. PUIA D, Ivanuta M, Pricop C
    DNA Methylation in Bladder Cancer: Diagnostic and Therapeutic Perspectives-A Narrative Review.
    Int J Mol Sci. 2025;26:7507.
    

    >> Share

    
    
26. PAVALEAN MI, Dobre M, Pelisenco IA, Madan VL, et al
    Association of miRNA-17-92 Cluster with Muscle Invasion in Bladder Cancer.
    Int J Mol Sci. 2025;26:7546.
    

    >> Share

    
    

    
    Int J Surg

27. ZHANG X, Zhang H, Shang P
    Comment on "innovative logic 'AND' gate gene circuits for bladder cancer treatment: preclinical study".
    Int J Surg. 2025 Aug 11. doi: 10.1097/JS9.0000000000003080.
    

    >> Share

    
    

    
    Int Urol Nephrol

28. XIANG X, Mei X, Song X, Pan B, et al
    High-density lectin microarray uncovers stage-specific plasma glycoprofiling signatures for non-muscle-invasive and muscle-invasive bladder cancer.
    Int Urol Nephrol. 2025 Aug 10. doi: 10.1007/s11255-025-04708.
    

    >> Share

    
    

    
    J Immunother Cancer

29. XIAO J, Liu J, Zhang C, Liu Z, et al
    Overcoming immunotherapy resistance in bladder cancer with a novel antibody-drug conjugate RC48.
    J Immunother Cancer. 2025;13:e011881.
    

    >> Share

    
    

    
    J Korean Soc Radiol

30. LEE H, Kwon H, Kim CW
    Minimizing Blood Loss in Bladder Cancer: Efficacy of Preoperative Embolization before Transurethral Resection of Bladder Tumor.
    J Korean Soc Radiol. 2025;86:512-523.
    

    >> Share

    
    

    
    J Mater Chem B

31. CHENG TY, Chiu YC, Chen KH, Chen YJ, et al
    Correction: Galactosylated silver nanoparticles as a biocompatible intrinsic SERS probe for bladder cancer imaging and ex vivo tumor detection.
    J Mater Chem B. 2025 Aug 11. doi: 10.1039/d5tb90125.
    

    >> Share

    
    

    
    J Pharmacol Exp Ther

32. KATARI V, Dalal K, Kondapalli N, Paruchuri S, et al
    Transient receptor potential vanilloid type 4 channels mediate bladder cancer cell proliferation, migration, and chemoresistance.
    J Pharmacol Exp Ther. 2025;392:103665.
    

    >> Share

    
    

    
    J Voice

33. LAGOS-VILLASECA A, Koshkin VS, Kinet MJ, Rosen CA, et al
    Laryngeal Mucous Membrane Pemphigoid as an Immune-related Adverse Effect of Pembrolizumab Treatment.
    J Voice. 2025;39:890-895.
    

    >> Share

    
    

    
    Lab Invest

34. SEOK J, Kwak HJ, Kang CK, Kim AR, et al
    Corrigendum to 'Development of a Technique for Diagnosis and Screening of Superficial Bladder Cancer by Cell-Pellet DNA From Urine Sample' [Laboratory Investigation 105 (2025) 104124].
    Lab Invest. 2025;105:104225.
    

    >> Share

    
    

    
    Med Phys

35. DU Y, Li H, Sui Y, Tao Y, et al
    Habitat-based radiomic model for predicting muscle invasion in bladder cancer: A multi-center study using enhanced-CT and machine learning.
    Med Phys. 2025;52:e18021.
    

    >> Share

    
    

    
    Mol Cell

36. MINIKES AM, Liu P, Wang H, Hu J, et al
    HIF-independent oxygen sensing via KDM6A regulates ferroptosis.
    Mol Cell. 2025;85:2973-2987.
    

    >> Share

    
    

    
    Sci Rep

37. LU K, Chao L, Wang J, Wang X, et al
    Suppressive effects of Momordica charantia MAP30 on the senescence, proliferation and migration of bladder cancer cells mediated by CENPA.
    Sci Rep. 2025;15:29679.
    

    >> Share

    
    

    
    Tissue Cell

38. YANG Y, Chen Y, Liu Q, Guan L, et al
    Fusobacterium nucleatum promotes bladder cancer progression and immune escape by activating the IL22/STAT3/PD-L1 signaling cascade.
    Tissue Cell. 2025;97:103065.
    

    >> Share

    
    

    
    Transl Androl Urol

39. YANG F, Qiu K, Deng J
    Unveiling SNX10: a key player in bladder cancer progression.
    Transl Androl Urol. 2025;14:1912-1924.
    

    >> Share

    
    

    
    Transl Cancer Res

40. XU X, Yan M, Xie Z, Zhang Y, et al
    Identification and validation of a novel signature based on M2 macrophage co-expressed genes in bladder cancer.
    Transl Cancer Res. 2025;14:4194-4207.
    

    >> Share

    
    

    
    Transl Oncol

41. HAN Y, Liu C, Wu G
    Letter to the editor: Prognostic biomarker PSMD14 facilitates bladder cancer tumorigenesis and progression by regulating Nucleolin-YAP1 axis.
    Transl Oncol. 2025;61:102498.
    

    >> Share

    
    

    
    Urol Oncol

42. HO M, Lazarovich A, Saoud R, Dahmen A, et al
    Bacillus Calmette-Guerin (BCG) in combination with PANVAC vs. BCG alone in adults with high-grade BCG-refractory non-muscle-invasive bladder cancer.
    Urol Oncol. 2025 Aug 7:S1078-1439(25)00222-4. doi: 10.1016/j.urolonc.2025.
    

    >> Share

    
    

    
    Urology

43. SMITH AB, Gore JL, Chisolm S, Squires P, et al
    Muscle-Invasive Bladder Cancer Treatment Selection in an Emerging Treatment Era: A Patient Preference Study.
    Urology. 2025 Aug 12:S0090-4295(25)00767-8. doi: 10.1016/j.urology.2025.
    

    >> Share

    
    

    
    World J Surg Oncol

44. ZHU G, He Y, Wang S, Huang J, et al
    Extraperitoneal vs transperitoneal laparoscopic cystectomy: optimized surgical techniques and long-term outcomes in a single-center retrospective cohort study.
    World J Surg Oncol. 2025;23:310.
    

    >> Share

    
    

    
    Zhonghua Nan Ke Xue

45. ZHOU XD, Shi N, Wang JJ, Wang X, et al
    [Expressions of androgen receptor and human epidermal growth factor receptor 2 in urinary bladder urothelial carcinoma with incidental prostate cancer and clinicopathological features of the malignancy].
    Zhonghua Nan Ke Xue. 2024;30:1081-1085.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share